The Russian President Vladimir Putin has said that Russia is ready to transfer Covid-19 vaccine technology and to expand production abroad.
The remarks by the Russian president on Saturday came a day after the government officials in India said that Serum Institute of India has received a preliminary approval from the country’s drug regulator for manufacturing of Sputnik V vaccines.
In April, 2021 Indian pharma company, Dr Reddy’s Laboratories has already received the Emergency Use Authorization (EUA) for the Russian vaccine.
Also Panacea Biotec in collaboration with Russian sovereign wealth fund RDIF has begun the production of Sputnik V vaccine in India.
Rejecting allegations over Sputnik V vaccine’s efficacy, the Russian president, during a virtual interaction with senior editors of major international news agencies, has said that the delay in getting the vaccine registered in Europe was due to a “competitive struggle” and “commercial interests” there.